Background: Globally 1.4 billion people are at risk from cholera in countries where the disease is endemic, with an estimated 2.8 million cases annually. The disease is significantly under reported due to economic, social and political disincentives as well as poor laboratory resources and epidemiological surveillance in those regions. In addition, identification of cholera from other diarrhoeal causes is often difficult due to shared pathology and symptoms with few reported cases in travellers from Northern Europe. Methods: A search of PubMed and Ovid Medline for publications on cholera diagnosis from 2010 through 2017 was conducted. Search terms included were cholera, Rapid Diagnostic Test (RDT), multiplex PCR and diagnosis of diarrhoea. Studies were included if they are published in English, French or Spanish. Results: An increase of RDT study publications for diarrhoeal disease and attempted test validations were seen over the publication period. RDTs were noted as having varied selectivity and specificity, as well as associated costs and local resource requirements that can prohibit their use. Conclusions: Despite opportunities to employ RDTs with high selectivity and specificity in epidemic areas, or in remote locations without access to health services, such tests are limited to surveillance use. This may represent a missed opportunity to discover the true global presence of Vibrio cholerae and its role in all cause diarrhoeal disease in underdeveloped countries and in travellers to those areas. The wider applicability of RDTs may also represent an opportunity in the wider management of traveller's diarrhoea.
Introduction
Vibrio cholera is a Gram-negative halophilic facultative anaerobe bacterium that has been subject to longstanding research into the disease's pathogenesis, which has laid the foundation of effective measures to prevent outbreaks of cholera around the world.
1,2 Despite our collective understanding of cholera it remains a substantial burden on world health resource. For example, in 2010, 700 000 Haitians were infected with cholera, proving fatal in over 9000 cases. 3, 4 Two serotypes of Vibrio cholera have been identified that cause cholera, O1 and O139. These classifications are made on the basis of an O-methylation of an O antigen on the surface of the bacterial cells. The O1 serogroup can also be further classified into two subgroups: the 'Classical' and 'El Tor' biotypes. Contemporary epidemics of cholera have been perpetuated by the O1 El Tor strain, with the O139 serogroup identified in 1992 as genetically derived from El Tor. 5 
Cholera and the Clinician-Symptoms and Treatment
Cholera symptoms are often indistinguishable from other causes of diarrhoea when mild. According to the WHO, cholera should be suspected in cases where patients of 5 years or over develop severe dehydration or die to due to acute watery diarrhoea, and in cases in patients of 2 years and above in regions known to have endemic cholera or that are suffering from a cholera epidemic. 1 Cholera epidemics are also frequently conjoint with humanitarian crisis and failures in infrastructure that allow the introduced infected faeces of a carrier to propagate in a population, with cyclical epidemics linked to weather patterns such as monsoon seasons, declining levels immunity within the local population, increased antibiotic resistance and factors such as climate change. 6 Climate change itself is a contributor to cholera epidemics as it can lead to more frequent increases of cholera levels in host organisms found in aquatic reservoirs, primarily coastal waters and estuaries. 1, 7 Cholera infection occurs orally by the ingestion of contaminated water and/or food, with an infectious dose estimated to be between 10 5 and 10 8 bacterial cells; however, as the strongly acidic nature of the stomach provides the body's first line of defence, infectious doses of 10 3 may be sufficient in individuals with achlorhydria. 1 Other susceptibility factors include retinol (Vitamin A) deficiency as well as genetically attributable factors, for example, blood group O is associated with more severe cholera and may account for the low prevalence of this blood group in South Asia. 1, 8 Cholera has an incubation period of between 12 h and 5 days. 9 In 2016, globally, 38 countries reported a total of 132 121 cases including 2420 deaths resulting in an overall case fatality rate of 1.8%. However, 47 imports were seen in Europe in 2016; with knowledge of the incubation time, but with ignorance of diagnostic difficulty, the figure could be interpreted as a rough indication of low risk to travellers.
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Cholera and the Traveller
Travelling to regions where cholera is endemic is an acknowledged risk factor for the traveller. [10] [11] [12] [13] [14] It is highly probable that areas which become endemic are prone to assisting the transmission cycle of Vibrio cholerae through the inadequate separation of faeces from food and water sources. 15 Destinations for the Northern European traveller that thus represent a risk, based on the latest WHO surveillance data, include the countries of Eastern Africa. Popular safari countries recording high levels of cholera infection in 2016 include Kenya (5866 confirmed cases) and for the period 2015-18 Tanzania (33 421). 10, 16 The difficulty in cholera detection in the traveller comes from symptom spotting and a historic lack of availability of detection methods to pin down the ultimate cause of the traveller's diarrhoea. 15 The causes of travellers' diarrhoea (TD) depend on destination, setting, and season. Studies of all cause TD have been performed in travellers, but few have involved detection of V. cholerae. 15, [17] [18] [19] Enteric bacteria are documented as the most common causes of traveller's diarrhoea: Escherichia coli, Campylobacter, Salmonella and Shigella spp. 3 Enterotoxigenic E. coli (ETEC) produces a heat labile and heat stable toxin. It is the most common species of E. coli cited in travellers' diarrhoea. 20 The heat labile toxin is shared with V. cholerae. 3 Hypothetically a shared pathological pathway could result in under-reporting of cholera, but RCTs using detailed methodology in returning travellers have shown this not to be the case. 18 
Identifying Causative Pathogens in Diarrhoeal Disease
Whilst microbial culture on selective media and antibody testing remain the gold standards for diagnostic confirmation of diarrhoeal pathogens, such assays are often difficult in the resourcelimited settings where the large majority of cholera cases are found. Culture testing requires samples to be sent to a suitably equipped laboratory, with trained staff and can take up to 2 days. 21, 22 Dark field microscopy can provide a rapid alternative and less lab intense method for diagnosis; however, sensitivity of this technique is only 50% when compared to culture. 1 Thus there is an interest in other methods involved in the detection of enteric pathogens such as standard polymerase chain reactions (PCR), real-time PCR and immunoassays. Patients with diarrhoea shed multiple pathogens which complicates assessment of etiology. Quantitative real-time PCR approaches can detect bacterial, viral and parasitic pathogens simultaneously using matched nucleic acid pairing across multiple laboratories with high sensitivity and excellent reproducibility and quantification. 23 As an indication of specificity, an infectious agent can be identified in over 80% of individuals with TD using research techniques which include PCR. 24, 25 Similar to culture methods, PCR diagnostics inherently favour identification of the most abundant pathogen. A false-negative result most likely occurs in the case of a low copy pathogen in a stool sample together with one or two highly abundant pathogens. For example one of the most commonly identified pathogens in stools of patients with TD is ETEC, which can create a false negative for low copy pathogens when in high volumes. 26 To combat this issue, a multiplex quantitative PCR test has been developed to detect common diarrhoea associated pathogens in <6 h. 27 It reliably detects enteric bacteria (diarrheagenic E. coli, Campylobacter, Shigella, Salmonella), viruses (norovirus, rotavirus and adenovirus) and parasites (Giardia, Cryptosporidium and E. histolytica). 28, 29 The problem with this diagnostic approach is cost, and the lack of validation for cholera. 29 Price may also prohibit routine use in evaluating patients with acute TD, with a single essay costing~$750. These expensive assays are likely more appropriate for persistent diarrhoea cases and research rather than acute travel related morbidity. 27 A recent study by Deng et al. 30 investigated the presence of enteropathogens in 290 stool samples from patients with diarrhoea in Southern China using such a multipanel nucleic acid test, the xTAG-GPP assay. They found that 159 (54%) out of the 290 stool samples were positive for enteropathogens. On comparing the use of xTAG-GPP assay vs conventional methods, the co-infection rates detected were of 12.1 and 10%, respectively. The sensitivity was 100% for all the targets except Salmonella and C. difficile with 84.9 and 88.6%, respectively. Vibrio cholera, sensitivity was not established. The panel was also limited to 15 bacterial and viral species, and the cost and ease of transport may make the use of the xTAG-GPP assay inapplicable to cholera detection. 30 
Diagnosing Cholera
As per other bacterial causes, the usual approach for patient diagnosis and for surveillance of cholera is based on clinical examination of suspected cases, with confirmation by positive culture of stool specimens in reference laboratories. Cell culture is very specific and is considered the reference-standard method in most countries for cholera. Phenotypic diversity means isolation of V. cholera (VC) strains is required for antibiotic susceptibility testing. 31 However, successful cell culture is, the skill required for sampling and delays in shipment can significantly affect the efficacy of culture as a primary diagnostic tool. Cholera also requires additional molecular subtyping to determine toxin subtype.
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Cholera is associated with unsanitary conditions and poor infrastructure. Delays in outbreak detection and a lack of control measures in such environments-due to the reliance on culturecan ultimately lead to unreliable estimates of the cholera burden. 33 The advent of molecular testing has become an alternative to culture for identification of many pathogens with antigen and nucleic acid methods developed for the identification of V. cholera species and characterization of O1 and/or O139 serogroups. [34] [35] [36] Since 2010 numerous studies have compared nucleic acid amplification tests, such as PCR to techniques such as conventional culture, Multiplex PCR to standard culture and to direct antigen detection, standard to multiplex PCR, PCR to molecular detection, and the assessment of quantitative PCR and sero-conversion. 29 Overall those studies that included cholera detection emphasize the large variations in diagnostic performance of PCR with regard to sensitivity and specificity, figures ranging from 58 to 100% and between 60 and 100%, respectively. 7 However, a word of caution is that these figures may have been effected by limitations in study design and may have underestimated test specificity. 7 PCR is evolving but is still reliant on a laboratory of healthcare setting. Point-Of-Care (POC) Testing devices for cholera are being made available using such technology, that provide a complete 'lab-on-a-chip' process thereby circumventing the need for a central testing laboratory and can be used by semi-skilled health professionals in the field. 37 7, 37, 38, 42 The immunological tests have can lack a more precise diagnosis of the cholera strain compared to PCR, as are unable to quantify the amount of V. cholerae present. Cholera RDTs in their simplest form are an immune chromatographic test device: a dipstick that is dipped into a tube containing the specimen and applied to reagents, the liquid is then analysed via a cassette where the specimen is applied to a sample well. The ELISA and monoclonal antibody basedpairing test then allows molecular specificity. 21 The tests provide a rapid (<30 min) qualitative result of a coloured band that can be read with the naked eye. They are fast, affordable, easy to use and require minimal infrastructure. 21 As such, they are well suited to meet the demand for cholera diagnosis in areas where culture or PCR based methods are not feasible. Cholera RDTs could therefore be employed to quickly identify cholera cases in a population at the time of a crisis. 37, 38 While PCR has the problem of low copy nucleic acid obfuscation in the separation and determination of species the single species ELISA tests can fail to differentiate between endotoxins of closely related species. 43 Lateral flow devices that detect the lipopolysaccharide of V. cholerae O1 and O139 via immunochromatographic assays, are the most common cholera RDTs. 44, 45 Despite their advantages, there are also significant limitations to the lateral flow RDTs. Evidence to guide their use is limited, and most studies conducted with Crystal VC, the most widely used RDT, demonstrate suboptimal specificity. 7 The Crystal VC dipstick is cheap and provides results within 15-20 min and is similar to a pregnancy test in that the appearance of bands on the strip of the dipstick are used to diagnosis the presence of cholera within a stool sample or swab. 46 Whilst the Crystal VC dipstick is sensitive it suffers from a relatively low specificity. In field trials users of the dipstick found it easy to distinguish between positive and negative results, due to its recognizable positive signal. 47, 48 Previous evaluations of Crystal VC have demonstrated a sensitivity ranging from 58 to 100% and specificity ranging from 60 to 100%. [46] [47] [48] [49] [50] [51] [52] [53] In Haiti, this test has been evaluated twice, demonstrating sensitivities of 95.0 and 95.6%, and specificities of 79.5 and 80.0%. 33, 49, 50 An enriched version of this test that involves incubation of the sample prior to testing improves the test performance considerably (specificity: 100%; sensitivity: 86%). However, this also adds considerable time to the display of a result, and increases the complexity of the test and the resources required. 52 The determination of cholera from other causes of gastrointestinal infection has not been studied using rapid test kits, and the specificity of the tests particularly against ETEC needs to be closely scrutinized when using immunoassays that target the lipopolysaccharide toxin of V. cholera, which shares an 80% similarity with E. coli heat labile endotoxin. 54 Less pragmatic laboratory based tests capable of differentiation such as PCR are currently required such as the cholera Genosensor kit, with high specificity (100%) and sensitivity (down to 10 CFU/μl) for cholera strains. 55 In terms of detecting multiple strains of cholera simultaneously, a POC cholera testing method called Vch-UPT-LF has been also developed, 56 which is an up-converting phosphor technologybased lateral flow (UPT-LF) assay with a dual-target detection mode ( Figure 1 ). It was developed to detect V. cholerae O1 and O139 simultaneously from one sample loading opposed to two separate immunogen tests. 57 Although applying an independent reaction pair made both detection results for the two Vch-UPT-LF detection channels more stable, the sensitivity slightly declined from 10 4 to 10 5 colony-forming units (CFU) mL −1 compared with that of the single-target assay. The Vch-UPT-LF strip showed excellent specificity for seven Vibrio species that are highly related genetically, and nine food-borne species-including ETEC-whose transmission routes are similar to those of V. cholerae. 56 However, the test is also subject to higher degree of expertise. There is significant variation in the performance of different cholera diagnostic RDTs. Some have high sensitivity and low specificity. 58 The suboptimal characteristics (specificity, 95% CI:
64.7-76.9%) 55 of these tests likely limit their use as clinical POC tests as differentiation of diarrhoeal cause is limited to a false positive for cholera; although, they may be useful for outbreak response, surveillance and research in resource-limited settings. 52 Concordant with these findings WHO recommendations for the use of RDTs are constricting: as they highlight use at primary healthcare level for surveillance purposes only, rather than for diagnosis of bacterial cause. RDTs are seen by the guidance as a method for triage of specimens for laboratory confirmation via culture or laboratory based PCR. 59 The guidance is written with some consideration to the environment of cholera settings in its identification of disposable point of care RDTs but likely has undue reliance on culture, when test PCR sensitivity can exceed 95%. 22, 33 Holistically, and local to Northern Europe, the identification of cholera as a causal species in returning cases of travellers' diarrhoea may be of direct relevance to the clinical community in determining antimicrobial pharmacotherapy, as resistance patterns emerge. This is in addition to any interest in identifying a defined number of returning cases and colloquial problem areas. The utility of RDTs with high specificity for cholera, or more common causative agents such as ETEC, may be of relevance for travellers in areas of known cholera epidemicity, when travellers consider pharmacotherapy in a remote location. 60 Assisting the selection of an appropriate antibiotic by a travel health professional or aiding otherwise empirical treatment, in an effort to tackle antimicrobial resistance. 61 
Conclusion
The advent of RDTs offers an opportunity for quick identification of cholera from other the causes of diarrhoea. The emerging availability of these tests mean an accurate diagnosis of cholera as diarrhoeal cause could be made quickly in a remote setting aiding local containment efforts. A role for cholera RDTs in Northern European travellers is less clear. Other disposable tests, such as ELISA based systems for ETEC, may have a role in the identification of TD cause and avoid unnecessary remote empirical antimicrobial therapy by the traveller. More complex laboratory tests such as PCR have been applied in controlled trails identifying TD cause, while cholera has not shown to be an infective agent in such samples a role for PCR in reducing healthcare burden locally, by identifying diarrhoeal cause and controlling antibiotic resistance, has been identified. 
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